[Selection of contrast media for hemodynamic studies and limitation of the associated risk].
Both the choice of contrast media for use in the cardiac catheterization laboratory, and the practice for limiting patient damage, are relevant to the quality of health care. As part of our quality assurance program, and as a preliminary step to a critical reappraisal of our current protocols, an updated review has been made of existing evidence about contrast media for this use, and about measures to prevent adverse events. Consideration was also given to evidence-based measures or drug treatment in patients at risk for anaphylactoid reactions or with renal failure, as well as to the recommended course of action in diabetic patients receiving oral biguanide agents.
Baralis
Giorgio
G
Struttura Semplice di Emodinamica, Dipartimento di Malattie Cardiovascolari, A. O. S. Croce e Carle, Cuneo. giorgiobaralis@hotmail.com
Steffenino
Giuseppe
G
Dellavalle
Antonio
A
La Scala
Eugenio
E
Uslenghi
Eugenio
E
D000367:Age Factors; D006328:Cardiac Catheterization; D003287:Contrast Media / Q000009:adverse effects / Q000493:pharmacokinetics; D003404:Creatinine / Q000097:blood; D003681:Dehydration / Q000150:complications; D004198:Disease Susceptibility; D004342:Drug Hypersensitivity / Q000209:etiology / Q000517:prevention & control; D006439:Hemodynamics; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control; D009994:Osmolar Concentration; D011785:Quality Assurance, Health Care; D012306:Risk; D012307:Risk Factors; D013927:Thrombosis / Q000139:chemically induced / Q000517:prevention & control
D003287:Contrast Media; D003404:Creatinine